<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>AminoX — Prospect Detail</title>
  <link rel="stylesheet" href="styles.css">
</head>
<body>
<header class="site-header"><h1>Prospect Detail</h1></header>
<div class="container">
  <a href="index.html" class="back-link">&larr; Back to All Prospects</a>
  <div class="detail-header">
    <span class="badge health" style="font-size:.8rem;">Digital Health</span>
    <h1>91. AminoX</h1>
    <p class="meta">Non-Standard Amino Acid Therapeutics</p>
  </div>
  <div class="section"><h3>1. Startup Name</h3><p><strong>AminoX</strong></p></div>
  <div class="section"><h3>2. Founder Contact</h3><p><strong>Wyss Institute Team</strong></p><p>Wyss Institute for Biologically Inspired Engineering at Harvard</p><p>Backed by Northpond Ventures</p></div>
  <div class="section"><h3>3. Product Overview</h3><p>AminoX develops a novel approach for incorporating non-standard amino acids into protein drugs. The platform expands the chemical diversity of therapeutic proteins, enabling the development of biologics with improved efficacy, stability, and safety profiles.</p></div>
  <div class="section"><h3>4. Funding Stage</h3><p><strong>Early Stage</strong> — Developing technology with Wyss Institute and Northpond support.</p></div>
  <div class="section"><h3>5. How I Found the Company</h3><p>Discovered through Wyss Institute and Northpond Ventures portfolio coverage.</p></div>
  <div class="strengths-weaknesses">
    <div class="section"><h3>Strengths</h3><ul><li><strong>Platform technology:</strong> Could improve multiple therapeutic proteins.</li><li><strong>Strong backers:</strong> Wyss and Northpond provide research and capital support.</li></ul></div>
    <div class="section"><h3>Weaknesses</h3><ul><li><strong>Early stage:</strong> Technology still in development phase.</li><li><strong>Complex manufacturing:</strong> Non-standard amino acids add production complexity.</li></ul></div>
  </div>
  <div class="section"><h3>7. Five Questions for the Team</h3><ol class="questions-list"><li>What therapeutic proteins are you initially targeting?</li><li>How do you manufacture proteins with non-standard amino acids at scale?</li><li>What improvements in efficacy or stability have you demonstrated?</li><li>Are you developing internal programs or partnering with pharma?</li><li>What is your regulatory pathway for modified biologics?</li></ol></div>
  <a href="index.html" class="back-link">&larr; Back to All Prospects</a>
</div>
</body>
</html>
